Free Trial

ImmunoPrecise Antibodies (IPA) Short Interest Ratio & Short Volume

ImmunoPrecise Antibodies logo
$0.35 -0.04 (-9.30%)
(As of 01:51 PM ET)

ImmunoPrecise Antibodies Short Interest Data

ImmunoPrecise Antibodies (IPA) has a short interest of 666,100 shares, representing 3.05% of the float (the number of shares available for trading by the public). This marks a 355.92% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.4, indicating that it would take 1.4 days of the average trading volume of 349,685 shares to cover all short positions.

Current Short Interest
666,100 shares
Previous Short Interest
146,100 shares
Change Vs. Previous Month
+355.92%
Dollar Volume Sold Short
$317,729.70
Short Interest Ratio
1.4 Days to Cover
Last Record Date
October 31, 2024
Outstanding Shares
28,830,000 shares
Float Size
21,810,000 shares
Short Percent of Float
3.05%
Today's Trading Volume
280,308 shares
Average Trading Volume
349,685 shares
Today's Volume Vs. Average
80%
Short Selling ImmunoPrecise Antibodies?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for ImmunoPrecise Antibodies and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

IPA Short Interest Over Time

IPA Days to Cover Over Time

IPA Percentage of Float Shorted Over Time

ImmunoPrecise Antibodies Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/2024666,100 shares $317,729.70 +355.9%3.1%1.4 $0.48
10/15/2024146,100 shares $83,277.00 -19.8%0.7%0.7 $0.57
9/30/2024182,200 shares $116,425.80 +65.9%0.8%1.1 $0.64
9/15/2024109,800 shares $73,566.00 -2.1%0.5%0.9 $0.67
8/31/2024112,100 shares $84,635.50 +16.1%0.5%1.3 $0.76
8/15/202496,600 shares $86,940.00 -4.1%0.5%1.1 $0.90
7/31/2024100,700 shares $79,452.30 -14.4%0.5%1.4 $0.79
7/15/2024117,700 shares $114,992.90 -15.7%0.6%1.6 $0.98
6/30/2024139,600 shares $140,996.00 -8.0%0.7%1.8 $1.01
6/15/2024151,700 shares $159,285.00 -7.8%0.7%1.7 $1.05
5/31/2024164,600 shares $184,352.00 -18.1%0.8%1.3 $1.12
5/15/2024201,000 shares $230,808.30 -35.5%0.9%0.4 $1.15
4/30/2024311,500 shares $392,490.00 -8.4%1.5%0.5 $1.26
4/15/2024340,000 shares $421,600.00 +6.9%1.6%0.6 $1.24
3/31/2024318,200 shares $483,664.00 -27.8%1.5%0.5 $1.52
3/15/2024440,700 shares $634,608.00 +1,290.2%2.0%0.8 $1.44
2/29/202431,700 shares $58,328.00 -37.6%0.2%0.1 $1.84
2/15/202450,800 shares $100,584.00 +232.0%0.2%0.4 $1.98
1/31/202415,300 shares $27,693.00 -38.3%0.1%0.1 $1.81
1/15/202424,800 shares $41,168.00 +31.2%0.1%0.2 $1.66
12/31/202318,900 shares $32,319.00 -34.8%0.1%0.2 $1.71
12/15/202329,000 shares $40,020.00 +2.1%0.1%0.3 $1.38
11/30/202328,400 shares $44,588.00 -2.1%0.1%0.3 $1.57
11/15/202329,000 shares $42,050.00 -38.3%0.1%0.4 $1.45
10/31/202347,000 shares $108,269.20 +99.2%0.2%0.7 $2.30
10/15/202323,600 shares $30,208.00 -48.3%0.1%0.4 $1.28
9/30/202345,600 shares $83,448.00 +2.9%0.2%1 $1.83
9/15/202344,300 shares $77,968.00 -2.0%0.2%1 $1.76
8/31/202345,200 shares $85,428.00 +52.2%0.2%1.1 $1.89
8/15/202329,700 shares $67,315.05 -24.0%0.1%0.8 $2.27
7/31/202339,100 shares $98,532.00 -22.6%0.2%0.5 $2.52
7/15/202350,500 shares $142,410.00 -3.6%0.2%0.6 $2.82
6/30/202352,400 shares $155,104.00 -46.0%0.2%0.6 $2.96
6/15/202397,000 shares $280,330.00 -1.2%0.4%1.1 $2.89
5/31/202398,200 shares $310,312.00 +0.3%0.4%1.1 $3.16
5/15/202397,900 shares $299,574.00 No Change0.4%1.1 $3.06
10/31/2022129,400 shares $643,118.00 -12.5%N/A8 $4.97
10/15/2022147,800 shares $691,704.00 +41.8%N/A9 $4.68
9/30/2022104,200 shares $415,758.00 +17.6%N/A6.4 $3.99
9/15/202288,600 shares $430,596.00 -19.3%N/A5.6 $4.86
Download Our Tesla Ebook For Free (Ad)

Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.

To claim your copy free of charge simply follow this link.
8/31/2022109,800 shares $585,234.00 -29.8%N/A7.4 $5.33
8/15/2022156,400 shares $828,920.00 -16.4%1.0%9.7 $5.30
7/31/2022187,100 shares $791,433.00 -6.7%1.1%11.7 $4.23
7/15/2022200,600 shares $762,280.00 -9.1%1.2%12.7 $3.80
6/30/2022220,600 shares $838,280.00 -4.8%1.3%10.5 $3.80
6/15/2022231,700 shares $919,849.00 -3.8%1.4%9.2 $3.97
5/31/2022240,800 shares $1.38 million +6.2%1.5%8.1 $5.73
5/15/2022226,800 shares $1.01 million -22.1%1.4%7.4 $4.45
4/30/2022291,300 shares $1.62 million -0.2%1.8%8.5 $5.56
4/15/2022291,900 shares $1.67 million +3.4%1.8%7.8 $5.72
3/31/2022282,200 shares $1.45 million +2.2%N/A0 $5.14
3/15/2022276,200 shares $1.09 million +0.2%1.6%7.5 $3.95
2/28/2022275,600 shares $1.36 million -16.8%1.6%7.5 $4.93
2/15/2022331,400 shares $1.70 million +21.8%1.9%7 $5.13
1/31/2022272,000 shares $1.68 million +16.5%1.6%5.7 $6.18
1/15/2022233,500 shares $1.46 million -24.8%N/A0 $6.26
12/31/2021310,300 shares $1.66 million -12.4%1.8%6 $5.36
12/15/2021354,200 shares $1.91 million +11.2%2.1%5.6 $5.38
11/30/2021318,500 shares $1.91 million +8.9%1.9%4.5 $6.00
11/15/2021292,500 shares $1.78 million -15.0%1.7%3.5 $6.10
10/29/2021344,200 shares $2.26 million -24.2%2.0%2.9 $6.57
10/15/2021454,100 shares $2.99 million +1.3%2.6%2.1 $6.58
9/30/2021448,200 shares $2.79 million -18.3%2.6%0.2 $6.22
9/15/2021548,800 shares $3.62 million -3.1%3.2%0.2 $6.60
8/31/2021566,400 shares $4.18 million -17.1%3.3%0.2 $7.38
8/13/2021682,800 shares $4.81 million +6.9%4.0%0.3 $7.05
7/30/2021638,500 shares $4.20 million +467.6%3.7%0.3 $6.58
7/15/2021112,500 shares $619,875.00 -23.5%0.7%0.1 $5.51
6/30/2021147,000 shares $884,940.00 +18.2%0.9%2.5 $6.02
6/15/2021124,400 shares $931,756.00 -8.0%0.8%1.7 $7.49
5/28/2021135,200 shares $1.06 million +42.3%0.8%1.7 $7.82
5/14/202195,000 shares $712,500.00 +11.8%0.6%1.2 $7.50
4/30/202185,000 shares $878,900.00 +2.8%0.5%0.9 $10.34
4/15/202182,700 shares $904,738.00 +386.5%N/A0 $10.94
3/31/202117,000 shares $150,280.00 +27.8%0.1%0.1 $8.84
3/15/202113,300 shares $153,083.00 -19.9%0.1%0.1 $11.51
2/26/202116,600 shares $222,108.00 +238.8%0.1%0.2 $13.38
2/12/20214,900 shares $68,845.00 -58.5%0.0%0.1 $14.05
1/29/202111,800 shares $200,600.00 +1,375.0%0.1%0.2 $17.00
1/15/2021800 shares $11,992.00 No Change0.0%0 $14.99

IPA Short Interest - Frequently Asked Questions

What is ImmunoPrecise Antibodies' current short interest?

Short interest is the volume of ImmunoPrecise Antibodies shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 666,100 shares of IPA short. 3.05% of ImmunoPrecise Antibodies' shares are currently sold short. Learn More on ImmunoPrecise Antibodies' current short interest.

What is a good short interest ratio for ImmunoPrecise Antibodies?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IPA shares currently have a short interest ratio of 1.0. Learn More on ImmunoPrecise Antibodies's short interest ratio.

What is a good short interest percentage for ImmunoPrecise Antibodies?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.05% of ImmunoPrecise Antibodies' floating shares are currently sold short.

Is ImmunoPrecise Antibodies' short interest increasing or decreasing?

ImmunoPrecise Antibodies saw a increase in short interest in the month of October. As of October 31st, there was short interest totaling 666,100 shares, an increase of 355.9% from the previous total of 146,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is ImmunoPrecise Antibodies' float size?

ImmunoPrecise Antibodies currently has issued a total of 28,830,000 shares. Some of ImmunoPrecise Antibodies' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ImmunoPrecise Antibodies currently has a public float of 21,810,000 shares.

How does ImmunoPrecise Antibodies' short interest compare to its competitors?

3.05% of ImmunoPrecise Antibodies' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to ImmunoPrecise Antibodies: Anebulo Pharmaceuticals, Inc. (0.12%), Lumos Pharma, Inc. (1.54%), Barinthus Biotherapeutics plc (0.02%), RAPT Therapeutics, Inc. (7.64%), Elevation Oncology, Inc. (12.42%), NextCure, Inc. (0.31%), OKYO Pharma Limited (1.11%), Carisma Therapeutics, Inc. (4.00%), Lexaria Bioscience Corp. (1.72%), Clene Inc. (2.91%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short ImmunoPrecise Antibodies stock?

Short selling IPA is an investing strategy that aims to generate trading profit from ImmunoPrecise Antibodies as its price is falling. IPA shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against ImmunoPrecise Antibodies?

A short squeeze for ImmunoPrecise Antibodies occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of IPA, which in turn drives the price of the stock up even further.

How often is ImmunoPrecise Antibodies' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IPA, twice per month. The most recent reporting period available is October, 31 2024.




This page (NASDAQ:IPA) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners